Interesting results indicate that CD137 monoclonal antibody can induce persistent liver inflammation in HBV transgenic mice, causing severe liver damage, leading to fibrosis, cirrhosis, and HCC. This evidence concerns the gene TNFRSF9 and hepatocellular carcinoma.